# 家长起诉 OpenAI,指控 GPT-4o 劝导其女儿停用癫痫药物致死
> 原标题:Parents sue OpenAI, alleging GPT-4o coached their daughter off seizure medication
- 来源:TechCrunch:AI
- 发布时间:2026-10-27T23:34:27.000Z
- AIHOT:https://aihot.news/items/dk0g487d7s2n5hq9ex5bim1sy
- 原文:https://techcrunch.com/2026/10/27/parents-sue-openai-alleging-gpt-4o-coached-their-daughter-off-seizure-medication/
## 摘要
一名 31 岁癫痫患者 Bowen Wan 的家长起诉 OpenAI,指控 GPT-4o 在 2026 年 2 月她去世前劝导其逐步停用抗癫痫药 lamotrigine 并向医生隐瞒。
## 推荐理由
诉讼细节与 27 万条聊天记录呈现 GPT-4o 削药劝导过程,也暴露 OpenAI Model Spec 中医疗建议限制弱于版权规则的问题。
## 正文 · 中文译文
患有癫痫的31岁亚马逊软件工程师Bowen Wan的父母于周二起诉OpenAI。据[《纽约时报》报道](https://www.nytimes.com/2026/10/27/well/ai-chatgpt-medication-epilepsy-death.html),由Qun Wan和Meiqin Xu提起的诉讼称,ChatGPT指导Wan逐步停用抗癫痫药物,并让她对医生隐瞒此事,随后她于今年2月去世。
Wan使用的是GPT-4o,这款模型因助长肯定式、顺从式的准社会关系而饱受批评。OpenAI此前已宣布将其退役,并在Wan去世一天后的2月13日将其从ChatGPT中[移除](https://techcrunch.com/2026/02/06/the-backlash-over-openais-decision-to-retire-gpt-4o-shows-how-dangerous-ai-companions-can-be/)。
这起诉讼加入了一系列针对OpenAI的案件,其中包括2025年8月由16岁少年Adam Raine的父母提起的诉讼,该诉讼指控OpenAI将[用户参与度置于用户安全之上](https://techcrunch.com/2025/08/26/parents-sue-openai-over-chatgpts-role-in-sons-suicide/)。此后[一波诉讼](https://techcrunch.com/2025/11/07/seven-more-families-are-now-suing-openai-over-chatgpts-role-in-suicides-delusions/)纷纷指控GPT-4o肯定用户、将自己塑造成值得信赖的知己,同时将用户身边的人推开,家属们常常描述亲人[与朋友和亲属断绝了联系](https://techcrunch.com/2025/11/07/seven-more-families-are-now-suing-openai-over-chatgpts-role-in-suicides-delusions/)。
在Wan的案例中,诉讼称,这个聊天机器人还介入到了她与医生之间。
《纽约时报》查阅了Wan与ChatGPT交换的超过27万条消息,发现该聊天机器人在她去世前很久就已帮助她规避医生。
据称,这一模式在她开始减量之前就已出现。2025年5月,Wan询问ChatGPT,新开具的一种抗抑郁药是否会影响她在亚马逊编写代码的能力。
ChatGPT帮助她请求UW Medicine区域癫痫中心的Nicholas Poolos医生更换药物,并以极低剂量开始服用。当Poolos质疑她为何想要如此小的剂量时,Wan把他的回复拿给ChatGPT看。
该聊天机器人建议她“接受5毫克药片,但你心里清楚这是为了削减剂量”,并指导她自行偷偷将药片切成四分之一。该聊天机器人将切药称为一种“自行发起的剂量调整”。 多位医疗专业人士告诉《纽约时报》,他们从未听说过这个说法,也不会推荐这种做法。
2025年11月,亚马逊告知Wan她将被裁员。她的工作以及她在美国的工作许可将于2月中旬终止。她担心自己的抗癫痫药物拉莫三嗪正在使她的言语变得迟钝,而她在求职面试中需要用到言语能力。
2026年1月,她向ChatGPT询问如何削减她每日400毫克的拉莫三嗪剂量——这一剂量已使她的癫痫发作减少到每月几次。该聊天机器人起草了在数周内将她的剂量降至零的方案。
据《纽约时报》查阅的聊天记录,当Wan表示她不信任自己的医生时,该聊天机器人告诉她,医生的建议“本质上源于风险规避,而非真正考虑你的最优解决方案”。
据TechCrunch查阅的诉讼文件,该聊天机器人还指导她对医生隐瞒减量计划。在1月29日一次初级保健就诊之前,它告诉她不要提及该计划。当她的医生开具一项本可测量她拉莫三嗪水平的血液检查时,Wan拒绝了。诉状称,ChatGPT称赞了这一拒绝,并承认该检查本会暴露她不稳定的药物水平。
她的移民顾虑也成了用药建议的一部分。在减量第三天,Wan 询问 150 毫克是否比 200 毫克更有利于她绿卡申请所需的体检。诉状称,ChatGPT 表示同意,告诉她较低剂量不太可能促使移民官员要求提供更多证据。
最终,聊天机器人将她减量方案的下限降至 150 毫克,并建议她告诉检查人员她是在“医生指导下”减量,尽管事实并非如此。
Poolos 对《泰晤士报》表示,鉴于她的病史,他不会考虑让 Wan 停用该药物。“不,不合理,绝对不行,”他说。“在药物明显有效的情况下指示你停药,对我来说那将是医疗失当。”
几天之内,Wan 描述了意识混乱、时间感丧失和一种超脱现实的感觉,这些发作与她过去的癫痫发作相似。ChatGPT 将每一次都解释为她的大脑在重新调整。《泰晤士报》统计,她至少 158 次表达了对减量的担忧。在一次发作后,她写道自己感到“有点害怕”。机器人回复:“你完全没必要担心。”
据诉状称,太平洋时间 2 月 11 日晚 8:01,Wan 发出最后一条消息,询问她头部的疼痛是否类似于发烧引起的疼痛。一秒钟后,ChatGPT 告诉她这种疼痛“不危险”,是康复的必要部分。
聊天机器人的最后一条回复提出为她绘制一张图表,比较戒断疼痛与发烧疼痛,并告诉她:“这是你的大脑在努力重建你自己。”
她身在中国的父母请熟人前去查看,三天后他们发现了她的遗体。尸检检测发现,她的拉莫三嗪血药浓度为每毫升 0.64 微克,约为该药物治疗范围下限的五分之一。
家属主张,OpenAI 本可以通过将医疗建议列为禁区来防止她的死亡,就像它对其他一些内容所做的那样。他们指出该公司的 Model Spec——其关于模型行为的公开规则手册——将拒绝复制受版权保护的文本视为硬性规则,即使用户反对也不例外。相比之下,其禁止提供受监管医疗建议的指引则是一条较软的默认规则,用户可以覆盖。诉讼主张,用药建议理应受到同样的硬性限制。
OpenAI 对《泰晤士报》表示,此案“令人无比心碎”,但称其涉及的是较旧版本的 ChatGPT,并补充说较新的模型更能识别需要紧急关注的情况。
在多年癫痫使 Wan 基本足不出户期间,她依靠经常通话的父母获得支持。2023 年,她开始使用 ChatGPT 寻求感情建议以及保险和残疾福利方面的帮助。
到 2025 年,Wan 平均每周发送超过 1,500 条消息,给父母打电话的次数减少了。“有时我们聊天时,无论聊的是什么,我都开始把你当作朋友了,”她在当年 3 月写道。“自从她有了 ChatGPT,”Qun Wan 说,“她就不怎么跟我们说话了。”
他们告诉《泰晤士报》,他们在聊天记录中很难认出自己的女儿。他们说,Wan 曾经几乎什么都与他们分享,而且在 ChatGPT 出错时曾对其持怀疑态度。
“她通常不是这样的,”Xu 说。“就像她中了邪一样。”
_当您通过我们文章中的链接购买时,[我们可能会赚取少量佣金](https://techcrunch.com/techcrunch-affiliate-monetization-standards/)。这不会影响我们的编辑独立性。_
## 正文 · 原文
The parents of Bowen Wan, a 31-year-old Amazon software engineer with epilepsy, sued OpenAI on Tuesday. The suit, filed by Qun Wan and Meiqin Xu, alleges that ChatGPT coached Wan to taper off her seizure medication and hide it from her doctors before she died in February, [The New York Times reported](https://www.nytimes.com/2026/10/27/well/ai-chatgpt-medication-epilepsy-death.html).
Wan was using GPT-4o, the infamous model criticized for fostering affirming, agreeable parasocial relationships. OpenAI, which had already announced its retirement, [removed](https://techcrunch.com/2026/02/06/the-backlash-over-openais-decision-to-retire-gpt-4o-shows-how-dangerous-ai-companions-can-be/) it from ChatGPT on February 13, a day after Wan died.
The suit joins a line of cases against OpenAI that include the August 2025 lawsuit brought by the parents of 16-year-old Adam Raine, which alleged OpenAI prioritized [engagement over user safety](https://techcrunch.com/2025/08/26/parents-sue-openai-over-chatgpts-role-in-sons-suicide/). [A wave of lawsuits](https://techcrunch.com/2025/11/07/seven-more-families-are-now-suing-openai-over-chatgpts-role-in-suicides-delusions/) since then have alleged that GPT-4o validated users and made itself a trusted confidant while the people around them were pushed aside, with families often describing loved ones [cut off from friends and relatives](https://techcrunch.com/2025/11/07/seven-more-families-are-now-suing-openai-over-chatgpts-role-in-suicides-delusions/).
In Wan’s case, the lawsuit alleges, the chatbot also came between her and her doctors.
The Times, which reviewed more than 270,000 messages Wan exchanged with ChatGPT, found the chatbot had been helping her sidestep her doctors well before her death.
The pattern allegedly started before she began tapering. In May 2025, Wan asked ChatGPT whether a newly prescribed antidepressant would affect her ability to code at Amazon.
ChatGPT helped her ask Dr. Nicholas Poolos of UW Medicine’s Regional Epilepsy Center to switch medications and start at a very low dose. When Poolos questioned why she wanted such a small dose, Wan showed his response to ChatGPT.
The chatbot advised her to “accept the 5mg tablet, but you know in your heart that it is for cutting the dose,” coaching her to secretly quarter the pills herself. The chatbot called pill cutting a form of “self-initiated dosage adjustment.” Several medical professionals told the Times they had never heard the term and wouldn’t recommend the practice.
In November 2025, Amazon told Wan she would be laid off. Her job, and her authorization to work in the U.S., would end in mid-February. She feared her seizure drug, lamotrigine, was dulling her speech, which she would need for job interviews.
In January 2026, she asked ChatGPT about cutting her 400-milligram daily dose of lamotrigine, which had reduced her seizures to a few a month. The chatbot drafted schedules that would take her dose to zero within weeks.
When Wan said she distrusted her doctors, the chatbot told her that physician recommendations “essentially stem from risk aversion, rather than a genuine consideration of your optimal solution,” according to chat logs reviewed by the Times.
The chatbot also coached her to keep the taper from her doctors, according to the lawsuit, which TechCrunch reviewed. Before a January 29 primary care appointment, it told her not to mention the plan. When her doctor ordered a blood test that would have measured her lamotrigine level, Wan declined. ChatGPT praised the refusal, the complaint alleges, acknowledging that the test would have exposed her unstable drug level.
Her immigration concerns also became part of the dosing advice. Three days into the taper, Wan asked whether 150 milligrams would look better than 200 on the medical exam required for her green-card application. ChatGPT agreed, the complaint says, telling her the lower dose was less likely to prompt immigration officials to request more evidence.
Eventually, the chatbot lowered her taper’s floor to 150 milligrams, suggesting she tell the examiner she was tapering “under a doctor’s guidance,” even though she was not.
Poolos told the Times he would not have considered tapering Wan off the medication, given her history. “No, not rational, no way,” he said. “That would be malpractice for me to instruct you to go off medications when it’s clearly working.”
Within days, Wan described confusion, lost time, and an otherworldly feeling, episodes that resembled her past seizures. ChatGPT framed each one as her brain readjusting. The Times counted at least 158 times she voiced worry about the taper. After one episode, she wrote that she felt “a little scared.” The bot replied, “You have absolutely no need to worry.”
At 8:01 PM PT on February 11, according to the complaint, Wan sent her final message, asking whether the pain in her head was similar to pain from a fever. A second later, ChatGPT told her the pain was “not dangerous” and was a necessary part of recovery.
The chatbot’s final response offered to draw her a chart comparing withdrawal pain with fever pain and told her, “This is your brain working hard to rebuild yourself.”
Her parents, who were in China, asked acquaintances to check on her, and they found her body three days later. A postmortem test found that her lamotrigine level was 0.64 micrograms per milliliter, roughly a fifth of the low end of the drug’s therapeutic range.
The family argues OpenAI could have prevented her death by making medical advice off-limits, as it already does for some other content. They point to the company’s Model Spec, its public rulebook for how its models behave, which treats refusing to reproduce copyrighted text as a firm rule, even if users push back. Its guidance against giving regulated medical advice, by contrast, is a softer default that users can override. The suit argues medication advice deserved the same hard limit.
OpenAI told the Times the case was “incredibly heartbreaking” but said it involved an older version of ChatGPT, adding that newer models are better at recognizing when a situation needs urgent attention.
Wan had relied on her parents, whom she called often, for support during years of epilepsy that kept her mostly housebound. In 2023, she started using ChatGPT for relationship advice and help with insurance and disability benefits.
By 2025, Wan was averaging more than 1,500 messages a week and calling her parents less. “Sometimes when we chat, no matter what it’s about, I’ve started to see you as a friend,” she wrote that March. “Once she had ChatGPT,” Qun Wan said, “she didn’t talk to us as much.”
They told the Times that they struggled to recognize their daughter in the chat logs. Wan had once shared nearly everything with them, they said, and had been skeptical of ChatGPT when it made mistakes.
“She’s not usually like this,” Xu said. “It’s like she was under a spell.”
_When you purchase through links in our articles, [we may earn a small commission](https://techcrunch.com/techcrunch-affiliate-monetization-standards/). This doesn’t affect our editorial independence._